Answers are grounded in this paper and cite their sources.
A nation-wide Rh prevention programme was started in Finland in 1969. Before that, a control series of approximately 1000 Rh-negative mothers giving birth to an Rh-positive child was collected to estimate the number of mothers with antibodies at either three, six, or nine months post partum. During the three-and-a-half year period altogether 14,980 Rh-negative patients were given 250 μg of anti-D immunoglobulin prepared from Finnish raw material in the Central Laboratory of the Dutch Red Cross. Out of those treated before the end of June 1972, 12,720 (97%) were tested four to six months post partum. Seventeen or 0·13% had detectable antibodies; in five of them the infant was ABO incompatible. The number of protected mothers with a subsequent Rh-positive infant was 1017; 10 had formed antibodies before the delivery of the second child. The risk of primary immunization initiated during a single pregnancy was estimated to be 0·35%. In addition, there was approximately a 0·60% risk of forming antibodies by the next Rh-positive pregnancy. The effect of prevention on the prevalence of haemolytic disease was calculated and compared with observed figures.
No takes yet. Share an insight, caveat, or question.
Eklund et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: